Hospira pulled all lots of its 16026 Symbiq One Channel Infusers and 16027 Symbiq Two Channel Infusers distributed at any time, warning that "the Symbiq pump touchscreen may not respond to user selection, may experience a delayed response or may register a different value from the value selected by the user," according to the FDA notice.